Your new post is loading...
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Bioscience News - GEG Tech top picks
8.8K views |
+2 today
Ecrins Therpeutics developes a drug candidate ET-D5 which is a First-in-Class small molecule with an original anti-vascular and anti-proliferative mechanism of action. The company aims to develop its drug candidates to clinical Proof of Concept;
www.geg-tech.com/Vectors